Ravidasvir plus sofosbuvir demonstrates high cure rate for people with hepatitis C genotype 4
START study shows that people starting HIV treatment earlier have better quality of life
South Africa’s XDR-TB epidemic is due to transmission rather than evolution of resistant strains
Maraviroc may work as PrEP in combination with another drug – but probably not by itself
Expanding treatment and PrEP could prevent 185,000 new HIV infections, US CDC says
Modest kidney function decline in people taking Truvada for PrEP supports need for monitoring
